About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Media coverage
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
Efficacy of second-line dolutegravir- versus boosted protease inhibitor-based ART in children and adolescents living with HIV at 96 and 144 weeks: pooled analysis of the ODYSSEY and CHAPAS-4 trials
Factors associated with HIV-1 DNA dynamics in early treated childrenwith perinatal HIV
“Four queer men in the UK have contracted monkeypox”:Grammar, agency, and stigma in media reporting of mpox outbreaks
British news media representations of the 2022 and 2024 mpox outbreaks:A corpus-assisted study
“That took me back to HIV in the ’90s”: Community reflections on public health responses to the 2022 mpox outbreak
Switching off dolutegravir in pregnancy during the safety signal period: a multi-cohort European study
Switching off dolutegravir in pregnancy during the safety signal period: a multi-cohort European study
Penta Young Reporters project wins Communiqué Award for Excellence in Patient Engagement
Otherness and blame: a comparative news media analysis of mpox outbreaks in Italy, Nigeria and the UK
Impact of Prior SARS-CoV-2 Infection on COVID-19 Vaccine Effectiveness in Children and Adolescents in Norway and Italy
The effect of policy measures, school holidays and travel on the incidence of SARS-CoV-2 infection in children and adults in Estonia from 2021 to 2022
Acceptability and perceptions of mpox vaccination and vaccine trials in pregnant women and infants during the PregInPoxVac trial in Boende, Democratic Republic of the Congo
Strengthening mpox vaccine trials through community engagement: Findings from workshops with women, healthcare professionals, and community leaders in Boende, Democratic Republic of the Congo (DRC)
Tolerability and Acceptability of Dispersible Oral Tablets of Amoxicillin and Co-Amoxiclav in African Children Hospitalized with Severe Pneumonia: Results from the PediCAP trial